This assay is to provide K562-based In Vitro Tumor Cell Target Expression Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
K562
Target Cell Organism
Human
Target Cell Background
K562 cells are of the erythroleukemia type, and the cell line is derived from a 53-year-old female chronic myelogenous leukemia patient in blast crisis. The cells are non-adherent and rounded, are positive for the bcr:abl fusion gene, and bear some proteomic resemblance to both undifferentiated granulocytes and erythrocytes.
Target Cell Alternative Name
K-562
Related Diseases
Chronic Myeloid Leukemia; CML
Research Area
Oncology
Assay Name
In Vitro Tumor Cell Target Expression Assay
Short Description
K562-cell based In Vitro Tumor Cell Target Expression Assay